- Home
- BMR vs RNXT Comparison
BMR vs RNXT Comparison
Compare BMR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- RNXT
- Stock Information
- Founded
- BMR 2009
- RNXT 2012
- Country
- BMR Israel
- RNXT United States
- Employees
- BMR N/A
- RNXT N/A
- Industry
- BMR Computer Software: Prepackaged Software
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- RNXT Health Care
- Exchange
- BMR Nasdaq
- RNXT Nasdaq
- Market Cap
- BMR 48.5M
- RNXT 44.6M
- IPO Year
- BMR 2023
- RNXT 2021
- Fundamental
- Price
- BMR $2.78
- RNXT $1.25
- Analyst Decision
- BMR
- RNXT Strong Buy
- Analyst Count
- BMR 0
- RNXT 2
- Target Price
- BMR N/A
- RNXT $7.50
- AVG Volume (30 Days)
- BMR 511.4K
- RNXT 339.0K
- Earning Date
- BMR 08-13-2025
- RNXT 08-14-2025
- Dividend Yield
- BMR N/A
- RNXT N/A
- EPS Growth
- BMR N/A
- RNXT N/A
- EPS
- BMR N/A
- RNXT N/A
- Revenue
- BMR $3,131,000.00
- RNXT $662,000.00
- Revenue This Year
- BMR $21.21
- RNXT $2,988.37
- Revenue Next Year
- BMR N/A
- RNXT $300.60
- P/E Ratio
- BMR N/A
- RNXT N/A
- Revenue Growth
- BMR 5.96
- RNXT N/A
- 52 Week Low
- BMR $1.86
- RNXT $0.75
- 52 Week High
- BMR $6.59
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- BMR 40.58
- RNXT 62.94
- Support Level
- BMR $2.69
- RNXT $0.90
- Resistance Level
- BMR $3.59
- RNXT $0.95
- Average True Range (ATR)
- BMR 0.29
- RNXT 0.08
- MACD
- BMR -0.03
- RNXT 0.03
- Stochastic Oscillator
- BMR 7.76
- RNXT 86.54
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.